SBI Securities’s Envoy Medical COCH Stock Holding History

SBI Securities’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1	Closed	-$1	–	4072
2025 Q3	$1	Buy	+1	New	+$1	﹤0.01%	4166
2025 Q1	–	Sell	-10	Closed	-$14	–	4145
2024 Q4	$14	Buy	+10	New	+$23	﹤0.01%	3887

Other funds holding COCH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return

ACP

Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SBI Securities's COCH Position: Q4 2025 in Review

SBI Securities sold out of Envoy Medical (COCH) in Q4 2025, closing a stake of 1 share — an estimated $1 sold.

SBI Securities first reported a position in COCH in Q4 2024 and held it in 2 quarters. The position peaked at $14 in Q4 2024. 27 funds tracked by Wall St. Rank hold COCH as of Q4 2025.

SBI Securities reported no remaining Envoy Medical position as of Q4 2025 after selling out during the quarter.
SBI Securities sold 1 Envoy Medical share in Q4 2025, an estimated $1.
SBI Securities first reported a position in Envoy Medical in Q4 2024 and held it in 2 quarters.
SBI Securities's Envoy Medical position peaked at $14 in Q4 2024.
27 funds tracked by Wall St. Rank held Envoy Medical as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.